| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Proteinase-activated receptor 4 |
|---|
| Ligand | BDBM176195 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | PAR4 FLIPR assay |
|---|
| Temperature | 298.15±n/a K |
|---|
| EC50 | 0.180±n/a nM |
|---|
| Comments | extracted |
|---|
| Citation |  Banville, J; Remillard, R; Ruediger, EH; Deon, DH; Gagnon, M; Dube, L; Guy, J; Priestley, ES; Posy, SL; Maxwell, BD; Wong, PC; Lawrence, RM; Miller, MM Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation US Patent US10047103 Publication Date 8/14/2018 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Proteinase-activated receptor 4 |
|---|
| Name: | Proteinase-activated receptor 4 |
|---|
| Synonyms: | Coagulation factor II receptor-like 3 | F2RL3 | PAR-4 | PAR4 | PAR4_HUMAN | Proteinase-activated receptor 4 | Proteinase-activated receptor 4 (PAR4) | Thrombin receptor-like 3 |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 41145.16 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q96RI0 |
|---|
| Residue: | 385 |
|---|
| Sequence: | MWGRLLLWPLVLGFSLSGGTQTPSVYDESGSTGGGDDSTPSILPAPRGYPGQVCANDSDT
LELPDSSRALLLGWVPTRLVPALYGLVLVVGLPANGLALWVLATQAPRLPSTMLLMNLAA
ADLLLALALPPRIAYHLRGQRWPFGEAACRLATAALYGHMYGSVLLLAAVSLDRYLALVH
PLRARALRGRRLALGLCMAAWLMAAALALPLTLQRQTFRLARSDRVLCHDALPLDAQASH
WQPAFTCLALLGCFLPLLAMLLCYGATLHTLAASGRRYGHALRLTAVVLASAVAFFVPSN
LLLLLHYSDPSPSAWGNLYGAYVPSLALSTLNSCVDPFIYYYVSAEFRDKVRAGLFQRSP
GDTVASKASAEGGSRGMGTHSSLLQ
|
|
|
|---|
| BDBM176195 |
|---|
| n/a |
|---|
| Name | BDBM176195 |
|---|
| Synonyms: | US10047103, 228 | US9688695, 228 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C25H18FN5O3S |
|---|
| Mol. Mass. | 487.506 |
|---|
| SMILES | COc1cc(OCc2csc(n2)-c2ccc(F)nc2)c2cc(oc2c1)-c1cn2nc(C)ccc2n1 |
|---|
| Structure | 
|
|---|
Search and Browse
